GRAFT is scheduled to get FDA approval in CY2025.
- Forums
- IPOs
- ReNerve IPO
ReNerve IPO, page-7
Featured News
Featured News
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online